<p>A, PSMA expression was detected by real-time PCR in LNCaP cells, normalized to PGD mRNA level. Cells were treated with vehicle DMSO or androgen antagonist flutamide for 2 hours prior to the treatment of the synthetic androgen R1881 for 24 hours. B, TMPRSS2-ERG fusion protein levels were checked by Western blot using anti-V5 antibody. LNCaP cells were transfected with fusion type III, III+72, VI, VI+72, or empty vector for 48 hours. C, Real-time PCR detected PSMA mRNA level in TMPRSS2-ERG fusion-transfected LNCaP cells. Cells were transfected with fusions or empty vector for 48 hours, then treated with or without R1881 for 24 hours. D, ERG expression level in ERG-transfected LNCaP cells by western blot. Cells were transfected with full le...
AbstractRecent studies have established that a significant fraction of prostate cancers harbor a sig...
Recurrent gene fusions between the genes TMPRSS2 and ERG have been described in prostate cancer (PCa...
Genome instability is a major characteristic in the development of cancer. In many tumours, specific...
<p>A, Expression levels of TMPRSS2-ERG in VCaP cells by real-time PCR, normalized to PGD mRNA level....
TMPRSS2-ERG fusion is the most common oncogenic rearrangement in prostate cancer (CaP). Due to this ...
Purpose: To gain insight in the mechanism and clinical relevance of TMPRSS2-ERG expression in prosta...
<p>A, Graphic prediction of ETS transcription factor binding site on PSMA promoter and recruitment o...
Many aspects of the mechanisms by which prostate cancer (PCa) progresses from being a confined tumou...
Many aspects of the mechanisms by which prostate cancer (PCa) progresses from being a confined tumou...
<p>A, Cells were transfected with different ERG siRNA by oligofectamine for 48 hours. ERG expression...
TMPRSS2-ERG gene fusions are the predominant molecular subtype of prostate cancer. Here, we explored...
Background: Fusion of the androgen-regulated gene transmembrane protease, serine 2, TMPRSS2, to the ...
Recent studies have established that a significant fraction of prostate cancers harbor a signature g...
Background: Fusion of the androgen-regulated gene transmembrane protease, serine 2, TMPRSS2, to the ...
AbstractTMPRSS2-ERG gene fusions are the predominant molecular subtype of prostate cancer. Here, we ...
AbstractRecent studies have established that a significant fraction of prostate cancers harbor a sig...
Recurrent gene fusions between the genes TMPRSS2 and ERG have been described in prostate cancer (PCa...
Genome instability is a major characteristic in the development of cancer. In many tumours, specific...
<p>A, Expression levels of TMPRSS2-ERG in VCaP cells by real-time PCR, normalized to PGD mRNA level....
TMPRSS2-ERG fusion is the most common oncogenic rearrangement in prostate cancer (CaP). Due to this ...
Purpose: To gain insight in the mechanism and clinical relevance of TMPRSS2-ERG expression in prosta...
<p>A, Graphic prediction of ETS transcription factor binding site on PSMA promoter and recruitment o...
Many aspects of the mechanisms by which prostate cancer (PCa) progresses from being a confined tumou...
Many aspects of the mechanisms by which prostate cancer (PCa) progresses from being a confined tumou...
<p>A, Cells were transfected with different ERG siRNA by oligofectamine for 48 hours. ERG expression...
TMPRSS2-ERG gene fusions are the predominant molecular subtype of prostate cancer. Here, we explored...
Background: Fusion of the androgen-regulated gene transmembrane protease, serine 2, TMPRSS2, to the ...
Recent studies have established that a significant fraction of prostate cancers harbor a signature g...
Background: Fusion of the androgen-regulated gene transmembrane protease, serine 2, TMPRSS2, to the ...
AbstractTMPRSS2-ERG gene fusions are the predominant molecular subtype of prostate cancer. Here, we ...
AbstractRecent studies have established that a significant fraction of prostate cancers harbor a sig...
Recurrent gene fusions between the genes TMPRSS2 and ERG have been described in prostate cancer (PCa...
Genome instability is a major characteristic in the development of cancer. In many tumours, specific...